Structure Therapeutics Target Price

Analysts' average 12-month price target for Structure Therapeutics is $91.

Get informed when a big investor buys or sells

+ Follow

Share Price

$47.34

Average Target Price

$90.50

91.2% upside

2 analysts in the last 4 months

High: $111 | Low: $70

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	Canaccord Genuity	$111	134.5% upside
2026-06-11	H.C. WainwrightAnanda Ghosh	$70	47.9% upside
2026-04-27	Canaccord Genuity	$101	113.4% upside
2026-03-17	BMO CapitalEvan Seigerman	$145	206.3% upside
2026-01-20	Guggenheim	$140	195.7% upside
2026-01-19	Goldman Sachs	$102	115.5% upside
2025-12-19	H.C. WainwrightAnanda Ghosh	$90	90.1% upside
2025-12-12	Morgan StanleyTerence Flynn	$125	164% upside
2025-12-11	Jefferies	$125	164% upside
2025-12-08	Stifel Nicolaus	$90	90.1% upside
2025-12-02	Stifel NicolausAnnabel Samimy	$50	5.6% upside
2025-11-28	H.C. WainwrightAnanda Ghosh	$60	26.7% upside
2024-09-23	Morgan StanleyTerence Flynn	$118	149.3% upside
2024-09-10	Piper SandlerYasmeen Rahimi	$93	96.5% upside
2024-08-09	JMP SecuritiesJonathan Wolleben	$86	81.7% upside
2024-06-07	BMO CapitalEvan Seigerman	$100	111.2% upside
2024-04-09	Cantor FitzgeraldPrakhar Agrawal	$65	37.3% upside

Structure Therapeutics (GPCR) FAQ

Structure Therapeutics's target price stands at $91. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $91 for GPCR implies 91.2% upside versus today's price ($47.34). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Structure Therapeutics's target price evolved across reporting periods, while the comparison chart places GPCR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.